- Home
- HCM vs SOC Comparison
HCM vs SOC Comparison
Compare HCM & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- SOC
- Stock Information
- Founded
- HCM 2000
- SOC 2020
- Country
- HCM Hong Kong
- SOC United States
- Employees
- HCM N/A
- SOC N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- SOC
- Sector
- HCM Health Care
- SOC
- Exchange
- HCM Nasdaq
- SOC Nasdaq
- Market Cap
- HCM 2.8B
- SOC 2.8B
- IPO Year
- HCM N/A
- SOC N/A
- Fundamental
- Price
- HCM $15.93
- SOC $22.33
- Analyst Decision
- HCM
- SOC Buy
- Analyst Count
- HCM 0
- SOC 4
- Target Price
- HCM N/A
- SOC $30.50
- AVG Volume (30 Days)
- HCM 59.1K
- SOC 2.0M
- Earning Date
- HCM 08-07-2025
- SOC 08-12-2025
- Dividend Yield
- HCM N/A
- SOC N/A
- EPS Growth
- HCM N/A
- SOC N/A
- EPS
- HCM 0.53
- SOC N/A
- Revenue
- HCM $602,197,000.00
- SOC N/A
- Revenue This Year
- HCM $2.73
- SOC N/A
- Revenue Next Year
- HCM $17.33
- SOC $184.34
- P/E Ratio
- HCM $5.63
- SOC N/A
- Revenue Growth
- HCM N/A
- SOC N/A
- 52 Week Low
- HCM $11.51
- SOC $16.26
- 52 Week High
- HCM $21.50
- SOC $35.00
- Technical
- Relative Strength Index (RSI)
- HCM 50.35
- SOC 30.89
- Support Level
- HCM $14.69
- SOC $27.38
- Resistance Level
- HCM $15.50
- SOC $28.74
- Average True Range (ATR)
- HCM 0.29
- SOC 1.33
- MACD
- HCM -0.02
- SOC -0.80
- Stochastic Oscillator
- HCM 65.96
- SOC 6.53
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.